QLY BIOTECH GROUP CORP. (LQLY) Financial Statements
QLY BIOTECH GROUP CORP. (LQLY) files with the U.S. Securities and Exchange Commission under CIK 0001787123. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2022
- Revenue
- $0
- Net Income
- -$14.11 thousand
- Total Assets
- $0
- Net Cash from Operations
- -$14.21 thousand
Fiscal year ended Aug 31, 2022. Latest periodic SEC filing: Apr 13, 2023. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for LQLY in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History